As the COVID-19 pandemic continues to spread rapidly across the globe and claim numerous lives, health care systems of countries are coming under severe pressure. Governments globally, including Kenya, are taking measures to combat the effects of the COVID-19 pandemic and some, in liaison with pharmaceutical companies and research groups in the private sector, are continuously ramping up efforts to find a cure or vaccine; likely to be protected through patents.
Authors
John Syekei
Head of IP and Technology and Partner
Sidharth Shah
Senior Associate
Most Popular Insights
- South Africa: JSE proposed amendments to Listings Requirements – Financial reporting costs – By Mili Soni, Monday July 13, 2026
- Kenya: Unlocking success – How intellectual property due diligence and governance drive value in mergers and acquisitions transactions – By Daniel Mwathe, Alex Ndegwa, Sahara Ali, Thursday July 9, 2026
- South Africa: Cape Town Tax Court judgment on ‘dividend-stripping’ – By Barry Garven, Aneria Bouwer, Phuti Kgomo, Michael Rudnicki, Wednesday July 8, 2026
YOU ALSO MIGHT BE INTERESTED IN
South Africa: JSE proposed amendments to Listings Requirements – Financial reporting costs
13 July 2026 – The Johannesburg Stock Exchange published proposed amendments to the JSE Listings Requirements relating to financial reporting costs.BY Mili Soni
Kenya: Unlocking success – How intellectual property due diligence and governance drive value in mergers and acquisitions transactions
09 July 2026 – IP is a valuable business asset across sectors such as technology, pharmaceuticals, consumer goods, manufacturing and agriculture.BY Daniel Mwathe, Alex Ndegwa and Sahara Ali
South Africa: Cape Town Tax Court judgment on ‘dividend-stripping’
08 July 2026 – Following its Constitutional Court win against ABSA Bank, CSARS has secured a victory in the Cape Town Tax Court over dividend stripping.BY Barry Garven, Aneria Bouwer, Phuti Kgomo and Michael Rudnicki

